Pfizer Bicillin L-A Prefilled Syringes Recalled for Improper Storage
Mckesson is recalling Bicillin L-A prefilled syringes stored outside label specifications. The FDA Class II recall affects 70 vials distributed to direct accounts in NM, AZ, and UT.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for improper storage outside drug label specifications represents a risk-of-harm product. Although no illnesses or injuries have been reported, storage deviations can compromise drug stability and safety, meeting the rubric criterion for High severity.
Plain-English summary
Bicillin L-A (Penicillin G Benzathine) 1.2 MMU prefilled syringes (NDC 60793-0701-10) manufactured by Pfizer Pharmaceuticals and distributed by Mckesson Medical-Surgical Inc. are being recalled because the product was stored outside the specifications listed on the drug label.
The FDA has classified this as a Class II recall. Approximately 70 vials with code 567951 were distributed to direct accounts in New Mexico, Arizona, and Utah.
The recalled product
- Product
- Bicillin L-A (Penicillin G Benzathine) 1.2, MMU / 2 mL Injection Prefilled Syringe 2 mL, Rx only, Mfg: Pfizer Pharmaceuticals, NDC 60793-0701-10
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Antibiotic / Injectable
- Hazard
- improper-storage
- gmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 567951
Distribution
Distributed in 3 states:
- AZ
- NM
- UT
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27